Article révisé par les pairs
Titre:
  • A pilot trial of recombinant human interleukin-10 in kidney transplant recipients receiving OKT3 induction therapy.
Auteur:Wissing, Karl Martin; Morelon, E.; Legendre, C; De Pauw, Luc; LeBeaut, A; Grint, P; Maniscalki, M; Ickx, Brigitte; Vereerstraeten, Pierre; Chatenoud, Lucienne; Kreis, H; Goldman, Michel; Abramowicz, Daniel
Informations sur la publication:Transplantation, 64, 7, page (999-1006)
Statut de publication:Publié, 1997-10
Sujet CREF:Sciences bio-médicales et agricoles
MeSH keywords:Adult
Antibody Formation
Cytokines -- biosynthesis
Dose-Response Relationship, Drug
Double-Blind Method
Drug Administration Schedule
Female
Fever -- prevention & control
Graft Survival -- immunology
Humans
Immunoglobulin M -- blood
Immunosuppressive Agents -- adverse effects
Interferon-gamma -- biosynthesis
Interleukin-10 -- administration & dosage
Interleukin-10 -- blood
Interleukin-10 -- therapeutic use
Interleukin-2 -- blood
Interleukin-8 -- blood
Kidney Transplantation -- immunology
Male
Muromonab-CD3 -- adverse effects
Pilot Projects
Recombinant Proteins -- administration & dosage
Recombinant Proteins -- blood
Recombinant Proteins -- therapeutic use
Tumor Necrosis Factor-alpha -- biosynthesis
Note générale:Clinical Trial
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langue:Anglais
Identificateurs:urn:issn:0041-1337
info:doi/10.1097/00007890-199710150-00012
info:scp/0343329759
info:pmid/9381549

Documents en relation

DI-fusion